Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-11-17

FDA Approved: ETODOLAC — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)

View source ↗

Summary

FDA approved a supplemental application for etodolac (generic) submitted by Taro Pharmaceuticals U.S.A., Inc., indicating a supplemental approval for this produ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etodolac (Etodolac)

Snippet

SUPPL AP for ETODOLAC (ETODOLAC)